Advanced estrogen receptor-positive (ER+) breast cancer can be especially difficult to treat. A new study by researchers at Dartmouth Cancer Center led by Todd W. Miller, Ph.D., shows promise in using ...
Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules ...
Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic therapies and PARP inhibitors could improve outcomes and combat cancer drug ...
The new public-private collaboration Insight Net is using advanced biosurveillance to respond to outbreaks and prevent future pandemics. Dylan George, director of the CDC's Center for Forecasting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results